Deerfield Management’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Deerfield Management’s Portfolio ORTX Stock Details ORTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-316,169	Closed	-$2.44M	–	235
2023 Q3	$2.44M	Hold	316,169	–	–	0.05%	72
2023 Q2	$1.65M	Hold	316,169	–	–	0.04%	87
2023 Q1	$1.7M	Sell	316,169 -2	-0%	-$11	0.04%	90
2022 Q4	$1.17M	Sell	316,171 -378,771	-55%	-$1.67M	0.02%	86
2022 Q3	$3.48M	Hold	694,942	–	–	0.07%	101
2022 Q2	$4.06M	Hold	694,942	–	–	0.08%	96
2022 Q1	$4.95M	Hold	694,942	–	–	0.11%	87
2021 Q4	$9.17M	Hold	694,942	–	–	0.19%	90
2021 Q3	$16M	Hold	694,942	–	–	0.31%	77
2021 Q2	$30.5M	Hold	694,942	–	–	0.54%	58
2021 Q1	$50.5M	Hold	694,942	–	–	1.06%	29
2020 Q4	$30M	Hold	694,942	–	–	0.59%	53
2020 Q3	$28.6M	Sell	694,942 -31,057	-4%	-$1.61M	0.7%	43
2020 Q2	$43.6M	Sell	725,999 -160,226	-18%	-$14.7M	1.27%	22
2020 Q1	$66.7M	Hold	886,225	–	–	2.12%	9
2019 Q4	$122M	Sell	886,225 -6,135	-0.7%	-$746K	3.89%	6
2019 Q3	$106M	Hold	892,360	–	–	4.32%	5
2019 Q2	$125M	Buy	892,360 +90,000	+11%	+$15.8M	4.48%	4
2019 Q1	$143M	Hold	802,360	–	–	5.5%	3
2018 Q4	$126M	Buy	+802,360	New	+$120M	5.05%	2

Other funds holding ORTX

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

BCM

Beryl Capital Management Redondo Beach, California $111M AUM 205.39% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

GCIA

Gabelli & Co Investment Advisers Rye, New York $688M AUM 63.39% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Deerfield Management's ORTX Position: Q4 2023 in Review

Deerfield Management sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q4 2023, closing a stake of 316,169 shares — an estimated $2.44M sold.

Deerfield Management first reported a position in ORTX in Q4 2018 and held it in 20 quarters. The position peaked at $143M in Q1 2019. 47 funds tracked by Wall St. Rank hold ORTX as of Q4 2023.

Deerfield Management reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q4 2023 after selling out during the quarter.
Deerfield Management sold 316,169 Orchard Therapeutics plc American Depositary Shares shares in Q4 2023, an estimated $2.44M.
Deerfield Management first reported a position in Orchard Therapeutics plc American Depositary Shares in Q4 2018 and held it in 20 quarters.
Deerfield Management's Orchard Therapeutics plc American Depositary Shares position peaked at $143M in Q1 2019.
47 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q4 2023.

Based on Deerfield Management's 13F filing for Q4 2023, filed 14 Feb 2024.